ECONOMIC EFFECTIVENESS OF THE ATTUNE® KNEE SYSTEM - ANALYSIS OF REAL WORLD HOSPITAL LENGTH OF STAY AND INCIDENCE OF EARLY COMPLICATIONS
Author(s)
Mantel J1, Corso KA2, Wei D2, Holy CE2, Muehlendyck C3, Jayakumar P4, Higgins M5, Westbrook A5
1DePuy Synthes, Leeds, UK, 2Johnson & Johnson, New Brunswick, NJ, USA, 3Johnson & Johnson Medical GmbH, Norderstedt, Germany, 4Johnson and Johnson Medical Devices, London, UK, 5Nottingham University Hospital, Nottingham, UK
OBJECTIVES: Briggs et al. highlight the importance of reducing hospital length of stay (LOS) and early post-operative readmissions to reduce the financial burden of elective orthopaedics. DePuy Synthes (DS) ATTUNE® Knee was engineered to enhance stability, thus potentially accelerating time to normal activities. This study was designed to evaluate whether patients treated with ATTUNE had a shorter LOS and less delayed discharge (DD) and post-operative events compared to patients treated with other implants. METHODS: Retrospective analysis of all primary adult TKAs at a single hospital within the United Kingdom between April 2014 and April 2015 was conducted. Three groups of patients were compared by implant type: ATTUNE, DS SIGMA® or Aesculap Columbus® RESULTS: In this study a total of 716 patients were included (ATTUNE: N=238, SIGMA: N=332, Columbus: N=149); 59.4% were female and had an average age of 69.2 (SD: 9.8). No significant differences were noted in age and sex; however, the proportion of patients ≥ CONCLUSIONS: In this study, patients treated with ATTUNE experienced significantly shorter LOS and fewer DDs compared to those treated with Columbus or SIGMA.
Conference/Value in Health Info
2017-11, ISPOR Europe 2017, Glasgow, Scotland
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PMD39
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Musculoskeletal Disorders